PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Faculty of Medicine, The Hebrew University, Jerusalem, Israel.\', \'Faculty of Medicine, The Hebrew University, Jerusalem, Israel; Department of Nephrology and Hypertension, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.\', \'Faculty of Medicine, The Hebrew University, Jerusalem, Israel; Clinical Virology Unit, Department of Microbiology and Infectious Disease, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.\', \'Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Faculty of Medicine, The Hebrew University, Jerusalem, Israel. Electronic address: luna@hadassah.org.il.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2059-7029(21)00245-310.1016/j.esmoop.2021.100283
?:hasPublicationType
?:journal
  • ESMO open
is ?:pmid of
?:pmid
?:pmid
  • 34634634
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all